Evaluation of Vitrase as a Spreading Agent

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

February 28, 2005

Conditions
Pain
Interventions
DRUG

Vitrase

Trial Locations (18)

11570

Ophthalmic Consultants of Long Island, Rockville Centre

30742

Advanced Eye Care, PC, Fort Oglethorpe

41017

Cincinnati Eye Institute NKY, Edgewood

57701

Black Hills Regional Eye Institute, Rapid City

64111

Hunkeler Eye Institute, Kansas City

67530

Donald E Beahm, MD, Great Bend

74104

David L Schwartz, MD, Tulsa

77025

Houston Eye Associates, Houston

77555

Ophthalmology Visual Science, Galveston

78209

David G Shulman, MD, San Antonio

78234

Ophthalmology Service, Brooke Army Medical Center, Fort Sam Houston

78666

Central Texas Eye Center, San Marcos

78705

Texan Eye Care PA, Austin

80120

E Randy Craven, MD, Littleton

92663

David Wirta, MD, Inc., Newport Beach

95815

Richard A Lewis, MD, Sacramento

06510

The Eye Care Group, New Haven

02114

Cornea Consultants, Boston

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY